However, in our current study, we did not observe any significant changes in NF-κB and IκB-α expression levels in NSCLC cells after KPT-185 treatment, but IκB-α and NF-κB was partially accumulated in nucleus in KPT-185 treatment group. The gene discussed is NFKBIA; the disease is non-small cell lung carcinoma.